QUALCOMM, Nutrien, Moderna among premarket losers' pack

franckreporter/iStock via Getty Images

• Aurinia Pharmaceuticals (AUPH) -30% on Q3 earnings release; lackluster Lupkynis uptake leads to guidance cut.
• Altice USA (ATUS) -27% on Q3 earnings release.
• Tandem Diabetes Care (TNDM) -26% on Q3 earnings release.
• Lincoln National (LNC) -25% on Q3 earnings release.
• Roku (ROKU) -20% on Q3 earnings release.
• Lumen Technologies (LUMN) -18% on Q3 earnings release.
• Rapid7 (RPD) -17% on Q3 earnings release.
• Peloton Interactive (PTON) -15% on FQ1 earnings release.
• Fortinet (FTNT) -14% on Q3 earnings release.
• China Liberal Education (CLEU) -13% on reports to acquire energy vehicle brand AIWAYS.
• Moderna (MRNA) -13% on Q3 earnings release.
• Surgalign (SRGA) -12% on Q3 earnings release.
• Maravai LifeSciences (MRVI) -12% on Q3 earnings release.
• Nutrien (NTR) -11% on Q3 earnings release.
• Butterfly Network (BFLY) -11% on Q3 earnings release.
• Cognizant Technology Solutions (CTSH) -11% on Q3 earnings release.
• Fisker (FSR) -11% on Q3 earnings release.
• Jowell Global (JWEL) -9%.
• Novavax (NVAX) -8% as Moderna cuts COVID vaccine outlook.
• QUALCOMM (QCOM) -8% on FQ4 2022 results mixed, co guides Q1 revenue below consensus.
• Lantheus (LNTH) -7% on Q3 earnings release.
• Quotient (QTNT) -10% notifies reverse stock split effective Nov.02.
• Sonoma Pharmaceuticals (SNOA) -7%.
• Sibanye Stillwater (SBSW) -7% on operating update for the three months ended 30 September 2022.
• AppLovin (APP) -7%.